These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29511224)

  • 21. Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin.
    Stevens WK; Nesheim ME
    Biochemistry; 1993 Mar; 32(11):2787-94. PubMed ID: 8457546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
    Anderson PJ; Bock PE
    J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for multiple enzyme site involvement in the modulation of thrombin activity by products of prothrombin proteolysis.
    Shi F; Hogg PJ; Winzor DJ; Jackson CM
    Biophys Chem; 1998 Dec; 75(3):187-99. PubMed ID: 9894338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase.
    Bradford HN; Krishnaswamy S
    J Biol Chem; 2016 May; 291(21):11114-23. PubMed ID: 27013660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states.
    Kamath P; Huntington JA; Krishnaswamy S
    J Biol Chem; 2010 Sep; 285(37):28651-8. PubMed ID: 20639195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meizothrombin is an unexpectedly zymogen-like variant of thrombin.
    Bradford HN; Krishnaswamy S
    J Biol Chem; 2012 Aug; 287(36):30414-25. PubMed ID: 22815477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1.
    Jenny L; Dobó J; Gál P; Schroeder V
    PLoS One; 2015; 10(12):e0144633. PubMed ID: 26645987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-canonical proteolytic activation of human prothrombin by subtilisin from
    Pontarollo G; Acquasaliente L; Peterle D; Frasson R; Artusi I; De Filippis V
    J Biol Chem; 2017 Sep; 292(37):15161-15179. PubMed ID: 28684417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zymogen and activated protein C have similar structural architecture.
    Stojanovski BM; Pelc LA; Zuo X; Di Cera E
    J Biol Chem; 2020 Nov; 295(45):15236-15244. PubMed ID: 32855236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation.
    Pozzi N; Chen Z; Zapata F; Pelc LA; Barranco-Medina S; Di Cera E
    Biochemistry; 2011 Nov; 50(47):10195-202. PubMed ID: 22049947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
    Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
    Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The linker connecting the two kringles plays a key role in prothrombin activation.
    Pozzi N; Chen Z; Pelc LA; Shropshire DB; Di Cera E
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7630-5. PubMed ID: 24821807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slow thrombin is zymogen-like.
    Huntington JA
    J Thromb Haemost; 2009 Jul; 7 Suppl 1(S1STATE):159-64. PubMed ID: 19630791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process.
    Brufatto N; Nesheim ME
    J Biol Chem; 2003 Feb; 278(9):6755-64. PubMed ID: 12496269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.
    Panizzi P; Friedrich R; Fuentes-Prior P; Kroh HK; Briggs J; Tans G; Bode W; Bock PE
    J Biol Chem; 2006 Jan; 281(2):1169-78. PubMed ID: 16230340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allostery in trypsin-like proteases suggests new therapeutic strategies.
    Gohara DW; Di Cera E
    Trends Biotechnol; 2011 Nov; 29(11):577-85. PubMed ID: 21726912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.
    Haynes LM; Bouchard BA; Tracy PB; Mann KG
    J Biol Chem; 2012 Nov; 287(46):38647-55. PubMed ID: 22989889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temperature dependence of the thrombin-catalyzed proteolysis of prothrombin.
    Shi F; Winzor DJ; Jackson CM
    Biophys Chem; 2004 Jul; 110(1-2):1-13. PubMed ID: 15223139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation.
    Lechtenberg BC; Johnson DJ; Freund SM; Huntington JA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14087-92. PubMed ID: 20660315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.